Former Acclarent Execs Convicted Of Misdemeanors In Off-Label Case

 
• By Elizabeth Orr

Two former executives from J&J's Acclarent division were found not guilty of felony charges but convicted on misdemeanor counts. Prior to being acquired by J&J, Acclarent allegedly marketed its Relieva Stratus sinus dilation device as a steroid-delivery system, even though the FDA had cleared the device only to deliver saline.

Gavel_1200x675
William Facteau and Patrick Fabian were found guilty of misdemeanors in the Acclarent off-label marketing case.

More from Legal & IP

More from Policy & Regulation